Metropolitan Life Insurance CO G1 Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$4.04 - $8.51 $11,025 - $23,223	-2,729 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$7.6 - $11.02 $20,740 - $30,073	2,729 New	2,729 $20,000
Q1 2022 Mar 30, 2023	SELL	$7.6 - $11.02 $31,441 - $45,589	-4,137 Reduced 60.25%	2,729 $20,000
Q1 2022 May 12, 2022	SELL	$7.6 - $11.02 $31,441 - $45,589	-4,137 Reduced 60.25%	2,729 $21,000
Q4 2021 Jun 21, 2023	BUY	$10.16 - $16.17 $69,758 - $111,023	6,866 New	6,866 $70,000
Q4 2021 Mar 30, 2023	SELL	$10.16 - $16.17 $16,012 - $25,483	-1,576 Reduced 18.67%	6,866 $70,000
Q4 2021 Feb 15, 2022	SELL	$10.16 - $16.17 $16,012 - $25,483	-1,576 Reduced 18.67%	6,866 $70,000
Q3 2021 Jun 21, 2023	BUY	$13.16 - $22.47 $111,096 - $189,691	8,442 New	8,442 $113,000
Q3 2021 Mar 30, 2023	SELL	$13.16 - $22.47 $34,808 - $59,433	-2,645 Reduced 23.86%	8,442 $113,000
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $34,808 - $59,433	-2,645 Reduced 23.86%	8,442 $113,000
Q2 2021 Jun 21, 2023	BUY	$19.57 - $26.32 $216,972 - $291,809	11,087 New	11,087 $243,000
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $216,757 - $291,520	11,076 Added 100690.91%	11,087 $243,000
Q1 2021 Jun 26, 2023	BUY	$17.58 - $32.59 $194,909 - $361,325	11,087 New	11,087 $267 Million
Q1 2021 May 14, 2021	SELL	$17.58 - $32.59 $194,716 - $360,966	-11,076 Reduced 99.9%	11 $267,000
Q4 2020 Jun 22, 2023	BUY	$10.99 - $20.4 $121,846 - $226,174	11,087 New	11,087 $199,000
Q3 2020 Jun 26, 2023	BUY	$11.55 - $23.75 $128,054 - $263,316	11,087 New	11,087 $128,000
Q2 2020 Jun 26, 2023	BUY	$9.57 - $24.37 $106,102 - $270,190	11,087 New	11,087 $268,000
Q1 2020 Jul 12, 2023	BUY	$9.07 - $26.32 $100,559 - $291,809	11,087 New	11,087 $122,000
Q4 2019 Jul 12, 2023	BUY	$20.54 - $31.0 $227,726 - $343,697	11,087 New	11,087 $293,000
Q4 2019 Mar 30, 2023	SELL	$20.54 - $31.0 $10,537 - $15,903	-513 Reduced 4.42%	11,087 $293,000
Q4 2019 Feb 14, 2020	SELL	$20.54 - $31.0 $10,537 - $15,903	-513 Reduced 4.42%	11,087 $293,000
Q3 2019 Jul 12, 2023	BUY	$22.78 - $40.58 $264,248 - $470,728	11,600 New	11,600 $264,000
Q3 2019 Mar 30, 2023	BUY	$22.78 - $40.58 $89,639 - $159,682	3,935 Added 51.34%	11,600 $264,000
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $89,639 - $159,682	3,935 Added 51.34%	11,600 $264,000
Q2 2019 Jul 12, 2023	BUY	$16.03 - $31.1 $122,869 - $238,381	7,665 New	7,665 $235,000
Q1 2019 Jul 13, 2023	BUY	$14.4 - $21.45 $110,376 - $164,414	7,665 New	7,665 $127,000
Q1 2019 Mar 30, 2023	BUY	$14.4 - $21.45 $110,376 - $164,414	7,665 New	7,665 $127,000
Q1 2019 May 16, 2019	SELL	$14.4 - $21.45 $86,068 - $128,206	-5,977 Reduced 43.81%	7,665 $127,000
Q1 2019 May 15, 2019	BUY	$14.4 - $21.45 $86,068 - $128,206	5,977 Added 77.98%	13,642 $86,000
Q4 2018 Jul 13, 2023	BUY	$16.51 - $51.33 $126,549 - $393,444	7,665 New	7,665 $146,000
Q4 2018 Feb 14, 2019	BUY	$16.51 - $51.33 $101,899 - $316,808	6,172 Added 413.4%	7,665 $147,000
Q3 2018 Jul 13, 2023	BUY	$43.15 - $67.97 $294,196 - $463,419	6,818 New	6,818 $357 Million
Q3 2018 Nov 14, 2018	SELL	$43.15 - $67.97 $229,773 - $361,940	-5,325 Reduced 78.1%	1,493 $78,000
Q2 2018 Aug 15, 2018	BUY	$35.06 - $51.17 $77,973 - $113,802	2,224 Added 48.41%	6,818 $0
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $87,515 - $191,845	4,594 New	4,594 $0

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account